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Split hand/foot malformation (SHFM) is a congenital limb malformation observed 
in humans characterized by a reduction or loss of the central digits of the hands and/or 
feet.  The condition affects one in every 8,500 to 25,000 births, accounting for 8-17% of 
all limb reduction defects.  A tandem duplication of approximately 500 Kb has been 
determined to be the causative mutation at the SHFM3 locus.  Patients that are 
heterozygous for this duplication have three copies of the genes BTRC, POLL, and 
DPCD as well as an extra copy of exons 6-9 of FBXW4.  The SHFM3 critical region also 
contains the FGF8 and SUFU genes.  The aim of this study was to determine if and 
where these genes are expressed during normal limb development in the chicken.  All the 
genes except poll at embryonic day 6 (E6) were detected by RT-PCR of cDNA from the 
limbs of E3-E13 embryos.  In situ hybridization of paraffin sections from limbs of the 
chicken at E6 and E8 showed that BTRC, DPCD, FBXW4, FGF8, and SUFU are 
expressed in the region of the limb where digit formation occurs.  Taken together, these 
data suggest that all of the genes, with the exception of POLL, may play a role in the 
development and patterning of the limb.  The duplication within this region found in 
patients with SHFM could cause the phenotype by altering the expression of these genes, 
either through an increase in expression of the duplicated genes, the removal of a gene 
from its regulatory element, or a combination of the two. 
This study also screened a cohort of patients with SHFM with an unknown 
molecular cause for mutations in two enhancer elements, o e located within intron 4-5 of 
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BTRC in the SHFM3 locus, and the other located within the SHFM5 locus.  Sequencing 
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AUTOPOD  The distal most region of the limb, hand or foot 
CLEFT LIP/PALATE Condition where tissue that form the lip or roof of  
  the mouth fail to fuse before birth 
CUTANEOUS  Pertaining to the skin 
ECTODERMAL DYSPLASIA Genetic condition characterized by failure to form 
 ectodermal derivatives  
ECTRODACTYLY  Absence of digits 
EXPRESSIVITY Extent to which a genotype is observed in an  
  individual 
MONODACTYLY  Having only one digit 
OSSEOUS  Pertaining to bone 
POLYDACTYLY  Having more than the normal number of digits 
PENETRANCE Frequency that a genotype manifests into a  
  phenotype 
STYLOPOD The long bone region of the limb near the body  
  wall, humerus/femur 
SYNDACTYLY  Fusion of the digits 
SYNTENIC  Conserved gene order between species 








Development of the Limb 
 
The vertebrate skeleton is generated from three different lineages: the somites 
which give rise to the axial skeleton, the lateral plate mesoderm which generates the limb 
skeleton, and the cranial neural crest which gives rise to the pharyngeal arches as well as 
the craniofacial bones and cartilage [1].  In the majority f the skeleton, osteogenesis is 
achieved through endochondral ossification, where a cartilage ntermediate is formed 
from mesodermal tissue, then replaced by a calcified matrix to form bone [1, 2].   
In chicken, the limb first emerges as a bulge on the side of the embryo at 
embryonic day three (E3).  As the bud elongates, distinct stylopod, zeugopod, and 
autopod elements become visible.  The autopod goes from a paddle like structure at E4 to 
visible digital demarcations at E6.  The digits continue to develop with webbing in 
between.  Individual digits form when apoptosis removes th  webbing, a process that is 
complete by E10.  In human, this occurs during the 4th-8th weeks of pregnancy. 
The limb initially forms when lateral plate mesoderm and somatic mesodermal 
cells proliferate and accumulate in a bulge under the ectod rm [1].  The positions of these 
limb buds are related to the level of Hox gene expression along the body’s cranial to 
caudal (head to tail) axis [1].  The cranial-most expression boundary of Hoxc5 and Hoxc6 
corresponds to the level at which the forelimb bud emerges in both mouse and chicken 
[3].  In the earliest stages of limb formation Fgf10 protein, which is produced throughout 
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the lateral plate mesoderm, becomes restricted to the regions where the limbs will form, 
due to the presence of Wnt proteins [4, 5].  Secretion of Fgf10 by these mesoderm cells 
initiates limb bud formation by Wnt3a mediated induction of Fgf8 expression, and 
initiates the interactions between the ectoderm and mesoderm [4, 5].  Expression of fgf8 
leads to the formation of the major signaling center of the developing limb, the apical 
ectodermal ridge (AER).  The AER is a thickened band of ect d rm along the distal 
margin of the limb bud and a major signaling center for the limb (Figure 1.1) [4].  The 
AER expression of fgf8 in turn induces continued expression of fgf10 in the mesoderm 
under the AER, as well as Shh expression in the posterior mesenchyme [4].  After the 
limb bud is established, expression of fgf10 and fgf8 become dep ndent on each other.  
Ectopic expression of one can rescue the loss of the other [4].  This interaction is 
hypothesized to be the molecular basis for the interactions between the AER and the 
underlying mesoderm [4].  Another feedback loop is established between fgf10 and shh.  
Shh induces further expression of fgf10, which in turn maintains shh expression [4]. 
Determination of forelimb and hindlimb occurs early, befor  emergence of the 
limb buds [6].  Tbx genes, a family of transcription factors, show expression in the flank 
mesoderm; Tbx5 in the region of the forelimb, Tbx4 in the hindlimb [6].  Members of the 
WNT family also play a role in determining forelimb and hindlimb; Wnt2b and Wnt8c 
restrict fgf10 expression to only the level of the forelimb and hindlimb, respectively. 
Proper development of the limb involves growth and patterning along three axes: 
proximal-distal (shoulder-fingertip), anterior-posterior (thumb-little finger), and dorsal-
ventral (knuckle-palm).  Each axis has its own signaling systems responsible for 
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patterning (Figure 1.1) and coordination of these three signalin  systems results in the 
correct limb pattern. 
 
Proximal-Distal (PD) Patterning 
 
 The prevailing model for PD patterning is the progress zonemodel, which states 
that the identity of a cell is determined by the amount of time it spends dividing in a 
region of undifferentiated mesoderm directly behind the AER, called the progress zone 
(Figure 1.1) [7, 8].  Cells that spend more time in the progress zone will form more distal 
structures in the autopod [9].  This model does not explain, however, the results obtained 
by Sun and coworkers in Fgf4 and Fgf8 double knockout mice where proximal elements 
are lost while normal distal elements develop [10].  Thealternate model, the early 
specification model, has also been proposed, stating that the cells are differentiated early 
to establish limb pattern. Subsequent growth of the limb, under the influence of the AER, 
expands these cell populations, leading to the sequential differentiation of structures that 
is observed [11] Research to examine these hypotheses is ongoing, and the data thus far 
does not exclude either model [12].  A temporal element has also been proposed, in 
which autopod elements along the PD axis form in correlation with the cyclic expression 
of hairy2 in the mesoderm [13].  This does not favor one model over another, it merely 




Figure 1.1: Major Signaling Centers of the Developing Human Limb 
Schematic of developing limb bud showing the major signaling centers the apical 
ectodermal ridge (AER) comprised of ectodermal tissue, the progress zone (PZ), and the 
zone of polarizing activity (ZPA), both composed of mesoderm.  Numbers represent the 
future digits 1 (thumb)-5 (little finger).  Orientation of each developmental axis is also 
shown. 
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 Dorsal-Ventral (DV) Patterning 
 
 DV patterning is the result of signals from the overlying ectoderm acting on the 
mesoderm below (Figure 1.1) [14].  Early in limb development, Wnt5a is expressed in the 
ventral ectoderm and Wnt7a in the dorsal ectodermal half [15].  Wnt7a induces the 
expression of Lmx1 in the dorsal mesoderm, an isoform of which, Lmx1b, appears to be 
responsible for dorsal compartmentalization of the limb [16, 17].  This 
compartmentalization of the mesenchyme does not contain all cells, nor does it correlate 
to any anatomical structures [17].  Instead of being a result of signaling centers, DV 
compartmentalization may be a result of the movement of mesenchymal cells through a 
three-dimensional space necessary for proper limb formation [17]. 
 
Anterior-Posterior (AP) Patterning 
 
 As the limb bud grows along the PD axis there is a widening of the distal region 
to prepare for the development of the digits [18].  At the posterior margin of the distal 
limb bud is a region of mesenchymal cells known as the zon  of polarizing activity (ZPA, 
Figure 1.1) [8].  This region secretes Sonic Hedgehog (Shh), which acts as a diffusible 
morphogen to regulate AP patterning [8, 19].  This diffusion sets up a concentration 
gradient across the autopod [8].  Posterior digit identity is specified by both the 
concentration of Shh and the amount of time that mesenchymal cells are exposed to Shh 
[20].  The pattern is further refined through interactions f Shh and its target gene Gli3, 
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where the presence of Shh promotes the Gli3 activator form (Gli3A) and prevents the 
repressor form of Gli3 (Gli3R) from forming [21].  Thus, a Gli3R counter-gradient is set 
up against the Shh gradient.  Digit identity is further specified by the ratio of 
Gli3A:Gli3R that cells are exposed to [22]. 
 It is further hypothesized that Shh patterns digits in a step wise manner, in which 
the protein first induces the cells to be competent to form digits, and then induces 
expression of Bmp2 which acts on this competent mesoderm to form digits [23].   
 BMP signaling has also been shown to regulate digit identity from the interdigital 
mesenchyme, downstream of ZPA signaling, before the interdigital mesenchyme 
regresses to form individual digits [24]. 
 
Coordination of the Three Axes 
  
 Coordinated signaling is not only required for proper limb formation, but 
signaling along one axis is often dependent on signals from another.  One such example 
is the positive feedback loop established between the AER and ZPA [25].  Shh from the 
ZPA induces Fgf4 expression in the AER, responsible for mesoderm proliferation [25].  
This in turn maintains Shh expression as well as makes the mesoderm directly under the 
AER receptive to Shh signals [25].  This enables Shh dependent AP pattering to continue, 
but because Shh induces expression of Hoxd genes responsible for specification of the 
zeugopod and autopod, PD patterning is also maintained [25, 26].  The dorsal Wnt7a 
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signal has also been shown to maintain Shh expression, demonstrating an interaction 
between the DV and AP axes [27]. 
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Split Hand/Foot Malformation (SHFM) 
 
SHFM is a congenital limb malformation characterized by a reduction or loss of 
the central digits of the hands and/or feet and affects one in every 8,500 to 25,000 births, 
accounting for 8-17% of all limb reduction defects [28, 29].  The phenotype is highly 
variable, ranging from mild changes in the digits, to monodactyly; with all of the limbs 
affected, or as few as one [30].  It is also common to see cutaneous and/or osseous 
syndactyly of the remaining digits (Figure 1.2) [30].  SHFM is clinically heterogeneous, 
presenting in both syndromic and non-syndromic forms [28].  The most common 
syndromic form of SHFM is the ectrodactyly, ectodermal dysplasia, cleft lip/palate 
(EEC) syndrome [28].  Non-syndromic SHFM can be either isolated or associated with 
deficiencies of the long bones (SHFLD) [28].  In familial cases, SHFM is often inherited 
in an autosomal dominant manner, although autosomal recessive and X-linked forms 
have been reported [28].  Families show incomplete penetrance, variable expressivity, 





Figure 1.2: SHFM phenotype, showing variable expressivity between patients, as 
well as within, the same patient.   
The top figure shows a patient with a normal left hand and SHFM of the right 
hand with syndactyly of the thumb and index finger.  The bottom figure shows a different 
patient, with both feet affected; the left foot more severely than the right.  From Everman 
DB. Hands and Feet. In: Stevenson RE, Hall JG, eds. Human Malformations and Related 
Anomalies, 2nd Ed. Oxford University Press: New York, 2006. 
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To date there are five well characterized loci for SHFM: SHFM1 at 7q21.3 [31], SHFM2 
at Xq26 [32], SHFM3 at 10q24 [33, 34], SHFM4 at 3q27 [35], and SHFM5 at 2q31 [36, 
37].  Recently, a sixth locus for SHFM has been suggested at 8q21.11-q22.3 [38].  For 
one locus, SHFM4, mutations in the TP63 gene have been identified as the causative 
mechanism for SHFM [35, 39]. 
 
The SHFM1 Locus 
 
 Patients with SHFM1 associated with 7q21 have been shown to have either a 
deletion or translocation including the genes DLX5, DLX6, and DSS1 [31, 40].  Hearing 
loss has also been associated with this locus [40, 41].  DLX5 (Gene ID 1749) is a member 
of a homeobox transcription factor family and is expressed in the neural tube, lens, and 
surface ectoderm of early stage chick embryos [42].  In later stages of chick development, 
Dlx5 expression is found in the wing and wing bones, as well as facial mesenchyme [43, 
44].  Another homeobox transcription family member, DLX6 (Gene ID 1750), and the 
DSS1 gene (Gene ID 7979) have not been studied in chicken.   
 Inactivation of both Dlx5 and Dlx6 in mouse results in bilateral ectrodactyly of 
the posterior limbs and craniofacial defects [45].  In this model the Dss1 gene is 
unaffected and mice heterozygous for the deletion do not show any phenotypic anomalies 
[45]. 
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 It is hypothesized that haploinsufficiency of the genes from this locus, either 
through deletion or the physical separation of the genes from a regulatory element(s) by 
chromosomal rearrangement [46] is the causative mechanism of SHFM1. 
 
The SHFM2 Locus 
 
 The SHFM2 locus was identified in a seven-generation family with multiple 
affected members, and linked to a 5.1 Mb region on Xq26.3 [32].  Faiyaz-Ul-Haque and 
coworkers studied several functional and positional genes from the critical region and 
found no mutations [32].  This is an extensive region, and it is possible that more genes 
have been identified since the original publication, which would require further 
examination.  Regulatory elements either in this region, or for genes within the locus, 
also cannot be ruled out as the causative mechanism for SHFM. 
 
The SHFM3 Locus 
 
Linkage analysis using several families identified the SHFM3 locus at 10q24 [33, 
34].  De Mollerat and coworkers identified a tandem duplication of approximately 500kb 
in this region that segregated with the phenotype as the causative mutation (Figure 1.3) 
[28, 29].  The duplication has been refined and the smallest region identified contains the 
entire BTRC, DPCD, and POLL genes, as well as exons 6-9 of FBXW4 (Figure 1.3)[28, 
47, 48].  Other genes of interest at this region are FGF8 and SUFU (Figure 1.3)[49].  
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While screening of these genes in SHFM cases has not found any causative mutations 
[49], the presumption is that this duplication causes the SHFM phenotype by altering the 
expression levels of one or more of the genes of this locus. This could be either by a 1.5 
fold increase in expression of the duplicated genes, or bydisrupting the regulation of 























































































































































































BTRC (Gene ID 8945) is a member of the F-box/WD40 protein family involved 
in two pathways responsible for AER maintenance, canonical Wnt signaling and NFκB 
[48].  As part of the ubiquitination process which targets proteins for further processing 
or degradation, BTRC is responsible for regulating β-catenin levels which have an effect 
on apoptosis [50, 51].  BTRC also recruits IκBα for degradation, allowing NFκB to 
translocate into the nucleus and activate its target genes [52].  As mentioned previously, 
Gli3 processing is a key component of AP patterning.  Wang and coworkers 
demonstrated that BTRC works downstream of protein kinase activity in Gli3 processing 
[53].  In lymphoblasts of patients with the SHFM3 duplication, BTRC is over expressed 
[48]. 
In the chicken model, btrc expression has been detected in neural tube and 
midbrain of Hamburger Hamilton (HH) stages 13-26 embryos [54, 55].  To date 
expression of this gene in the limb has not been reported. 
FBXW4 (Gene ID 6468) is also a member of the F-box/WD40 family implicated 
in the ubiquitination of proteins, but no specific pathway h s been identified [77].  The 
mouse homolog of this gene, Dactylin (Dac), is implicated in the naturally occurring 
Dactylaplasia mutant that serves as the current model for SHFM3 [49].  It is believed that 
Dac is responsible for AER maintenance by degrading a suppressor of AER cell 
proliferation [56].  The expression of this gene has not been r ported in the chicken. 
POLL, (Gene ID 27343) is a DNA directed repair polymerase of the PolX family 
of polymerases which is conserved in chimpanzee, dog, cow, m use, rat, chicken, 
zebrafish, Arapidopsis, and rice [57]  Expression of POLL has been found in a variety of 
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tissues, the highest in testis and fetal liver, but not in limb specific tissue.  There are no 
reports of studies of this gene having been conducted in chicken. 
DPCD (Gene ID 25911), a gene deleted in the mouse model for primary cili ry 
dyskinesia, is believed to be involved in the structure or function of cilia [58].  This gene 
has not been implicated in limb development specifically, but is expressed in human 
skeletal muscle [58].  At the time of limb bud formation n the chicken embryo (HH19), 
over half of the mesenchymal cells of the limb are ciliated, relating to the mitotic phase 
of the cell [59].  If this gene is involved in the formation or structure of these cilia, then 
misexpression of DPCD could impact cell division that is required for proper limb 
formation.  Expression of dpcd has not been reported in the chicken. 
FGF8 (Gene ID 2253), is a member of the FGF family and, as mentioned above, 
is one of the key signals involved in the maintenance of the AER.  In vitro FGF8 has 
been shown to stimulate osteoblast proliferation [60].  Another study has shown that Fgf8 
works with Indian hedgehog (Ihh) and through Sox9 to control the elongation of digits, 
implicating a role in distal cartilage element development [61].  The same study also 
indicated a role for Fgf8 in mesodermal cell differentiation [61].  Fgf8 has further been 
shown to work with Wnt3a to promote cell proliferation of limb progenitor cells, while 
maintaining them in an undifferentiated state [62] 
Studies in the embryonic chicken have shown that fgf8 expression is present 
starting from HH1-HH6 in the primitive streak [63, 64].  When the limb bud is present, 
fgf8 expression is detected in the AER, forebrain, somites, pharyngeal arches, and the eye 
[65-67].  At embryonic day 9 (E9) chick limbs, fgf8 expression is found in distal wing 
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muscle, near where the muscle attaches to bone [68], and also the facial mesenchyme 
[69]. 
SUFU (Gen ID 51684) is a member of the SHH pathway, preventing Gli1 from 
entering the nucleus and activating its target genes [70]. With strong expression detected 
in human testis, ovary, prostate, spleen, and peripheral blood leukocyte tissue, expression 
was also detected in skeletal muscle tissue [71].  BTRC and SUFU are believed to interact 
with each other, as SUFU interacts with the Drosophila slimb gene, which is homologous 
with BTRC [71].  Similar to BTRC, SUFU has been shown to be over expressed in the 
lymphoblasts of individuals with the SHFM3 duplication [48], and has been implicated in 
apoptosis by affecting β-catenin activity [72, 73]. 
In the chicken model, sufu expression is detected in the primitive streak, Hensen’s 
node, and the neural tube of early embryos and in the midbrain of embryos at the time of 
limb formation [55].  Expression has not been reported in the chicken limb. 
Of the genes from the SHFM3 critical region, only BTRC, FBXW4, FGF8, and 
SUFU have any known ties to limb development, and only FGF8 expression has been 
studied in the limb.  However, a sequential study of FGF8 expression through the stages 
of autopod development has not been reported. 
 
The SHFM4 Locus 
 
 The SHFM4 locus, located at 3q27, is the only SHFM locus for which the 
causative gene is clearly known [35, 39].  In this case, missense mutations in TP63 are 
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the causative mechanism for SHFM [35, 39].  TP63 is transcription factor, and these 
mutations are hypothesized to disrupt the DNA binding surface of the protein, reducing 
the transactivation activity of TP63. 
 
The SHFM5 Locus 
 
 A deletion of approximately 5Mb at chromosome 2q31 has been associated with 
the SHFM5 locus (Figure 1.4) [36, 37].  This critical region is 5’ to the HOXD cluster of 
genes, and contains the genes DLX1, DLX2, and LNP, all of which have been implicated 
in limb development [74, 75].  Although the closely related g nes, DLX5 and DLX6, are 
in the SHFM1 critical region, mice lacking Dlx1, Dlx2, or both Dlx1 and Dlx2 genes do 
not show limb anomalies [74, 76].  Lnp is shown to be expressed in the developing digits 
of the mouse [75].  Also within the deleted regions are SP3 and SP9, two transcription 
factors [77].  SP3 (Gene ID: 6670) can either stimulate or repress transcription of target 
genes by binding to their consensus GC- and GT-box regulatory elements [77].  Little is 
known about the specifics of SP9 (Gene ID: 100131390) activity, except for the 







Figure 1.4: SHFM5 critical region. 
2q31 showing the approximately 5 Mb region that is deleted in some patients with 
SHFM5.  The deletion is upstream of the gene Evx2 and the HOXD cluster and contains 




The Dactylaplasia Mouse Mutant 
 
In the mouse a spontaneous mutation resulted in the dactylaplasia (Dac) mouse with an 
SHFM like phenotype [56].  The manifestation of the phenotype is the result of mutations in two 
unlinked interacting genes, Modifier of dactylaplasia (Mdac) on chromosome 13 and dactylin on 
chromosome 19 [56, 78].  Mice must be homozygous for the rec ssive Mdac allele, regardless of 
the mutant dactylin alleles present, to exhibit the phenotype [78, 79].  At the dactylin locus, mice 
heterozygous for the mutation lack the central digits of the feet, whereas homozygotes present 
with only the most posterior digit [76].  The dactylin region is syntenic to human chromosome 
10q24, making the Dac mouse the current model for SHFM3 [78]. 
There are two known mutant alleles of dactylin, both resulting from insertions in the 
dactylin gene, equally sensitive to the effects of a homozygous rece sive Mdac allele, and have 
indistinguishable phenotypes [56].  The Dac1J allele is the result of an insertion of an early 
transposon repeat element upstream of the dactylin gene [56, 79].  The Dac2J allele is either an 
insertion or a small inversion in intron 5 of dactylin [56, 79].  It appears that the phenotype is 
caused by an inability to maintain the AER, though the exact me hanism remains largely 
unknown [56, 76, 79]. 
Populations of Dac1J and Dac2J mice were being maintained for the Greenwood Genetic 
Center’s research; however, problems with inbreeding have c used those populations to be lost.  






 The purpose of this study is to gain a better molecular h acterization of SHFM, 
specifically at the SHFM3 locus, and through pilot studies into the SHFM5 locus.  
Despite what is already known about the BTRC, POLL, DPCD, FBXW4, FGF8, and 
SUFU genes from the SHFM3 critical region, this data is insufficient to identify a 
causative gene. Studies of each gene’s expression pattern in he limb during the course of 
autopod development are limited.  This study aims to rectify this gap in our knowledge.  
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) will be used to sequentially 
study the timing of expression for each gene in the developing chicken limb.  Analysis 
will be done from the emergence of the limb bud, at E3, until digit formation, at E13, in 
both forelimbs and hindlimbs.  If these genes are expressed in the developing limb at this 
time, then in situ hybridization analysis will be employed to determine th spatial 
expression pattern in the limb. 
 Even with multiple identified or proposed loci, there a  still patients with SHFM 
for whom the molecular cause is unknown.  Given that t e causative mechanism at some 
of these loci involves complex chromosomal rearrangements, it cannot be ruled out that 
such rearrangements remove a gene from its regulatory element(s).  It also stands to 
reason that a mutation in a regulatory element could prevent proper gene expression.  The 
Lawrence Berkeley National Laboratory is currently using a mouse model to identify 
non-coding elements that have enhancer activity.  So far two such elements, which have 
been found to have enhancer activity in the limb, are located in SHFM loci.  One is 
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within an intron of BTRC in the SHFM3 locus; the other is in the SHFM5 critical region.  
This study will also screen a cohort of patients with SHFM for which the molecular cause 
has not been identified in either of these elements.   
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CHAPTER TWO 
MATERIALS AND METHODS 
 
Collection of Tissue and Isolation of RNA 
 
 White Leghorn eggs were incubated at 38.5°C until embryonic day 3 (E3) through 
E13.  At the appropriate stage, forelimb and hindlimb tissue was collected and stored 
separately in AllProtect Tissue Reagent(Qiagen). Numbers of embryos harvested were as 
follows: E3-5, 24; E6-8, 12; E9-11, 6; E12-13, 4.  RNA was isolated using the RNeasy® 
Lipid Tissue Mini Kit (Qiagen), and treated with Turbo DNA-free DNase kit (Ambion) to 




cDNA was synthesized from 10µg of RNA from each stage using the SuperScript 
II First Strand Synthesis kit (Invitrogen).  Intron spanning primers for the homologous 
genes from the SHFM3 locus as well as the 18S rRNA gene used as a control in chicken 
were designed using NCBI Primer BLAST (see Appendix).  PCR was performed with 
GoTaq polymerase as follows: 95°C for five minutes, then 30 cycles (40 cycles for fgf8) 
of 95°C for 30 seconds, the determined annealing temperature for the gene (see Appendix 
A-1) for 30 seconds, 72° for 35 seconds.  The final extension step was 72°C for seven 
minutes.  The resulting products were visualized on a 1% agarose gel. 
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Quantitative PCR (qPCR) 
 
 25 µl PCR reactions were set up as follows: 12.5 µl iQSYBR Green Supermix 
(Bio-Rad), 0.5 µl each of the appropriate forward and revers  p imers (See Appendix A-
2), 9.5 µl water and 2 µl cDNA (50 ng/µl).  Reactions were run on the Biorad iCycler iQ 
Multicolor Real Time Detection System under the following conditions: 50°C for 10 
minutes, 95°C for 5 minutes, 45 cycles of 95°C for10 seconds; 55°C for 30 seconds 
(camera on), followed by the melt curve generation: 95°C, one minute, 50°C, one minute, 
and 80 cycles of 50°C + 0.5°C increments, 10 seconds (camera on).  Results were 
analyzed using Gene Expression Macro ™ (Bio-Rad). 
 
Paraffin Embedding and Sectioning 
 
E6 and E8 limbs were harvested and fixed in a 4% Paraformaldehyde 
(PFA)/Phosphate Buffered Saline (PBS) solution overnight and rinsed twice with PBS for 
five minutes each.  Limbs were then dehydrated in 35%, 70%, 95% (2x), and 100% (2x) 
ethanol, five minutes each, before washing twice in NeoClar (Harleco), ten minutes 
each.  After washing in 1:1 NeoClear:Paraplast solution for 30 minutes at 60°C under 
vacuum, tissue was washed in Paraplast three times, 30 minutes each at 60°C under 
vacuum, before embedding in peel away molds.  10 µm sections were made on a 
microtome and placed in order on glass slides. 
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In Situ Hybridization Probes 
 
 For dpcd, fbxw4, and sufu probes, PCR products, generated as stated above, from 
E5 limbs were cloned into the pCR®2.1 vector and transformed into O e Shot® 
competent cells using the TA Cloning® Kit (Invitrogen).  The btrc and fgf8 probes were 
a gift from Dr. Susan Chapman.  Plasmids were minipreped using either the QIAPrep 
Spin® Miniprep Kit (Qiagen) for btrc, dpcd, fbxw4, and sufu probes or FastPlasmid Mini 
Kit (Eppendorf) for the fgf8 probe.  Purified plasmids were linearized by digestion with
XhoI (New England Biolabs) for dpcd, fbxw4¸and sufu, or BamHI (New England 
Biolabs) for btrc, and BamHI (Promega) for fgf8, using the buffers supplied for each 
enzyme. 
 The transcription labeling reaction for each probe was mixed on ice as follows: 10 
µl of 5X transcription buffer (Promega), 3 µl FITC RNA Labeling mix (Roche), 0.5 µl 
RNAse Inhibitor (Fisher), 2 µl T7 RNA Polymerase (Fisher), 1 µg of linearized template, 
and water to a volume of 50 µl.  The reaction mix was incubated for two hours at 37°C.  
Two microliters of DNaseI (Fisher) was added to the reaction mixture, for 15 minutes of 
incubation at 37°C.  Each product was cleaned using illustra™ ProbeQuant™G-50 Micro 
Columns (GE Healthcare), and checked for concentration on a 1% agarose gel. 
 
In situ hybridization on Limb Sections 
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Sections were baked on the slides for one hour before washing in NeoClear twice, 
for ten minutes each, and then rehydrated in 100% (2x), 95%, 70%, and 50% ethanol for 
three minutes each.  After rinsing with water for one minute, sections were fixed in 
PFA/PBS for ten minutes followed by 3% hydrogen peroxide in PBS solution (pH 7.4) 
for 20 minutes to remove peroxidases, and then washed with PBS for ten minutes.  Five 
minute active Diethyl Pyrocarbonate (DEPC) wash was used to rem ve RNases before 
treating slides with Proteinase K (4µg/ml) for 15 minutes to remove proteins.  Slides 
were washed three times, 10 minutes each, in PBS.  Tissue was permeabilized with a 
10% Tween-20 in PBS solution for 30 minutes and washed three tim s, 10 minutes each, 
in PBS.  Sections were dehydrated in 70%, 95%, and 100% ethanol for two minutes each 
before placing in a prehybridization solution (50% formamide, 5x SSC, pH4.5, 2% SDS, 
2% BBR, 250 µg/ml tRNA, 100 µg/ml Heparin) and incubated in a 63°C water bath for 
one hour.  Ten micrograms/ml of the appropriate probe wer  added to the slides and 
incubated overnight in a 63°C water bath. 
Unbound probe was removed by two 30 minutes washes in 1X SSC and two 30 
minute washes in 0.5X SSC, all in a 63°C water bath.  Slides were then rinsed with PBS 
for 5 minutes, and treated with SlowFade (Invitrogen), before fluorescence was 
visualized using a FITC filter on a Nikon SMZ 1500 fluorescence microscope. 
 
Screening of Candidate Enhancer Element Located in Intron 4-5 of BTRC 
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 PCR: Four pairs of overlapping primers were designed using Primer3 to cover the 
enhancer sequence provided by the Vista Enhancer Browser from the Lawrence Berkeley 
National Laboratory (see Appendix A-3 for sequences and anneali g temperatures).  PCR 
was performed on genomic DNA from 57 patients with SHFM of unknown cause with 
GoTaq polymerase as follows: 95°C for five minutes, then 40 cycles of 95°C for 30 
seconds, the determined annealing temperature for the primer pair (see Appendix A-2) 
for 30 seconds, 72° for 35 seconds.  The final extension step was 72°C for seven minutes.  
The resulting products were visualized on a 1% agarose gel. 
 Sequencing: Excess primers and dNTPs were removed from PCR products using 
ExoSAP-IT PCR Clean-Up Reagent (USB).  Sequencing reactions were carried out using 
the DYEnamic ™ ET Dye Terminator Kit (MegaBACE™) (GE Healthcare) under the 
following conditions: 95°C 20 seconds, 50°C for five seconds, 60°C for one minute, for 
27 cycles.  Products were analyzed on a MegaBACE and results xamined using 
DNAStar software. 
 RsaI digest to test for C391T change: PCR was performed as described above, 
using BTRC EN1 primers (see Appendix A-2), on 18 normal control samples and 38 
patients showing C391T change by sequencing stated above (27 heterozygous, 9 
homozygous).  Products were cut with RsaI (New England Biolabs) using the buffer 
supplied by the company.  Results were visualized on a 1% agarose gel 
 
Screening of the 3’ Sequence of Enhancer Element within SHFM5 Critical Region 
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 PCR and sequencing were performed as stated above, with an annealing 
temperature of 53°C used in the PCR.  See Appendix A-4 for primer sequences. 
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CHAPTER THREE 




Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was performed to 
determine if and when the genes from the SHFM3 region are expressed during limb 
development.  RNA was extracted from several forelimbs and pooled, similarly for 
hindlimbs.  
During normal limb development of the chicken, the wing ad leg buds emerge 
approximately 66 hours after the egg is laid [54].  The apical e todermal ridge (AER) 
becomes visible at E3, and the buds continue to grow along the proximal-distal axis, with 
the angle between the limb and the flank decreasing throug  rotation, from 90° to 45°.  
Demarcations of the future regions of the wing become apparent t E4, becoming more 
defined by E6.  At E5.5, the digital plate with the interdigital grooves begins to emerge.  
The groves become continue to deepen from E6 through to E7.5.  Digit II is separate 
from digit III by E8, with interdigital webbing completely removed by apoptosis by E9, 
with the appearance of the claw by E10 [80]. 
RT-PCR results indicate that btrc is present throughot the stages tested, dropping 
dramatically at E7.  Band intensity is strong again at E8, thereafter weakening in the 
forelimb and similarly weakening at E10 in the hindlimb (Figure 3.1).  The forelimb 
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sample at E3 has greater expression intensity than the hindlimb sample, which can be 
explained by the forelimb emerging ahead of the hindlimb (Figure 3.1).   
First detected at E3, sufu expression is strong at E3-6, E8 and E11-13, with weak 
expression detected at E7 and E10, with no expression at E9 in the forelimb (Figure 3.1).  
Hindlimbs show expression of sufu from E3-E10, and again at E12-13 (Figure 3.1), with 
E6-8, E10, 12, 13 being weaker.  This expression pattern is similar to that of btrc.   
Expression of fbxw4 is detected in forelimb samples at E3-6, E8, and at E12 and 
E13 (Figure3.1).  In the hindlimb samples, expression is detected at all stages, except E7 
and E11, with weak band intensity at E9, 12, and 13 (Figure 3.1).   
dpcd expression is evident at all stages in forelimb samples, with the exception of 
E10 (Figure 3.1).  In hindlimb, the only stage lacking expression i  E11.  Again, this is 
likely due to the delayed development of the hindlimb.  
Both forelimb and hindlimb samples had poll expression that was barely 
detectable at all stages, except for a jump in band intensity at E6 (Figure 3.1).  
In both forelimbs and hindlimbs, fgf8 expression was detectd for all stages, with 
bands of equal intensities, with the exception of undetectable expression at E9 in the 
hindlimb (Figure 3.1). 
In summary, the dynamic expression of btrc, fbxw4, sufu, and dpcd, suggested the 
need for quantitative approaches to better determine expression levels of these genes at 







Figure3.1: RT-PCR results from E3-E13  
Agarose gels of PCR products from cDNA isolated from forelimb (left column) and 
hindlimb (right column) of chick embryos at various embryonic stages. Forelimb (left column) 
and hindlimb (right column). Lanes are labeled with the embryonic stage number, ladder (L) and 
negative control lane using water (W) in the reaction mix, rather than cDNA.  btrc is present at all 
stages tested, with stronger band intensity at stages E3-E6 and E8 in forelimb samples and E4-E6, 
E8-E10, and E13 in hindlimb.  The pattern for sufu is similar to btrc with expression present at all 
stages except E9 forelimb samples, and E11 hindlimb, where exprssion is undetectable. Band 
intensity in fbxw4 samples is stronger in E3-E4, E6, E8, and E12-E13 in forelimb sa ples.  In the 
hindlimb, expression is stronger in E3-E6 and E8-E10 samples.  Bands were not present in E7 
and E9-E11 forelimb samples, or weakly at E7 and undetectabl in E11 hindlimb samples.  For 
dpcd, expression was detected at all stages except E10 in forelimbs and E11 in hindlimbs.  poll 
was only detected at E6 in both forelimb and hindlimb samples.  All stages shown, fgf8 
expression was observed, except for E9 in the hindlimb.  18SrRNA was used as a control to 
measure the quality of the cDNA.
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Quantitative PCR (qPCR) 
 
 To better understand how the expression levels of btrc, sufu, fbxw4, and dpcd 
change over the course of limb development, qPCR was perform d on cDNA from 
forelimb (Figure 3.2) and hindlimb samples (Figure 3.3).  The expression level of each 
gene was compared to that of 18S rRNA at the same stage.   
In forelimb samples, the expression ratio of the test g nes to the control gene is 
below one, indicating that 18S rRNA is an extremely robust gene. Other control genes 
such as actin or GAPDH may be preferential as control genes, as they are not as robustly 
expressed. Expression of btrc, fbxw4, and dpcd is greater during stages E4-8 than sufu, 
with a reversal from E9 through to E13, when sufu expression i  dominant.  From E3-8 
dpcd expression is higher than btrc, sufu, fbxw4 at E3, peaking at E4, then gradually 
down regulates to an undetectable level by E9. Expression of btrc and fbxw4 is highest at 
E4 and E6, with fbxw4 remaining robust at E7, whereas sufu dominated between E9-11. 
 In hindlimb samples, the expression ratio for the test g nes for most stages is 
below 0.5.  Exceptions to this are the expression of btrc is greater than 0.5 at E12, dpcd at 
E5, sufu at E9.  sufu exceeds 0.5 at E9, its peak and again exceeds 0.5 at E12.  The 
expression ratio for fbxw4 exceeds 0.5 at the most stages, first at E5, again at E9-10, 
peaking at nearly 2.5 at E12 and remaining above 0.5 at E13. 
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Figure 3.2: Quantitative PCR results of cDNA from E3-E13 forelimb samples  
The expression ratio of all of the genes tested to the control gene remains below 
one throughout the stages tested.  Expression of btrc, f xw4, and dpcd is greater during 
E4-8 than sufu expression, which is greater from E9-E13.  btrc expression is present at all 
stages, being highest at E4 and E6.  fbxw4 is also expressed at all stages, with the highest 
expression at E4, E6 and E7.  dpcd expression is lower than b rc and fbxw4 at all stages 
except E3, is highest at E4, and dropping to an expression rat  of zero from E9.  
Expression of sufu is lower than the other genes early on, surpassing them and peaking 
from E9-E11, remaining higher than the other genes through E13.  18S rRNA was used 





Figure 3.3: Quantitative PCR results of cDNA from E3-E13 hindlimb samples  
The expression ratio of the tested gene to the control gene for btrc is below 0.5 
through all stages tested except at E12 when btrc peaks at one.  sufu also stays below 0.5 
except at E9 and E12, rising higher at these two stages.  Expression of fbxw4 increases 
above 0.5 at E5, E9-10, peaks to almost 2.5 at E12, remaining above 0.5 at E13.  Similar 
to btrc, dpcd is below 0.5 at all stages, except E5 when it rises to a ratio of one.  18S 
rRNA was used as a control. 
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CHAPTER FOUR 
RESULTS: IN SITU HYBRIDIZATION 
 
 The Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) results indicate that all 
of the genes from the SHFM3 critical region, with theexception of poll, are expressed in the 
limb from the appearance of the limb bud through to the end of digit formation.  In situ 
hybridization was employed to determine where in the limb btrc, dpcd, fbxw4, fgf8, and sufu are 
expressed.  Weak or zero band intensity in the RT-PCR for nearly all of the genes at embryonic 
day seven (E7) suggests that a major change in developmental patterning is occurring at this 
stage.  Chondrogenesis of the nascent limb skeleton mesenchymal condensations begins at E6, 
with the onset of ossification detectable at E7.  Thus, down regulation of btrc, fbxw4 and sufu at 
this critical stage may be due to the onset of endochondral ossification of the skeleton elements 
in the limb.  To detect potential changes in expression in situ hybridization using probes for btrc, 





 btrc expression in E6 forelimbs is in specific mesoderm regions around the presumptive 
digits (Figure 4.1 A, C), and is weakly detectable surrounding the radius and ulna (Figure 4.1 A, 
B).  By E8, expression increases distally in the wrist and digit areas (Figure 4.1 E, F), localizing 
to the mesoderm underlying the surface ectoderm (Figure 4.1 E, F).   
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In E6 hindlimbs, expression surrounds the patella and femur (Figure 4.2 A), and is 
similar to the equivalent forelimb stage, with expression in the tibia and fibia (Figure 4.2 B). 
Expression is also detectable surrounding the forming digits II-IV (Figure 4.2 C, D).  In the E8 
hindlimbs expression is mainly in the proximal region of the foot (Figure 4.2 F), but not 

























































































































































































































































































































































































































































































































































































































































































































































Expression of dpcd, in E6 forelimbs, is restricted to the area immediately surrounding the 
radius, ulna.  Low levels of expression appear in the presumptive digits.  Higher levels of 
expression are observable in the proximal regions, than in the distal regions (Figure 4.3 A-B).  At 
E8, the expression level is only around the carpometacarpus in the distal region (Figure 4.3 C-D).   
Distally, E6 hindlimbs (Figure 4.4 A-B) also show greater expr ssion than forelimbs at 
the same stage (Figure 4.4 A-B).  Expression in the distal hind imbs, at E8, is also in the area 
immediately surrounding the bones, with no expression detectable in the distal most regions 







































































































































































































































































































































































































































































































































































































































































































































































In the E6 forelimb, fbxw4 expression is detected only around the presumptive digits, 
mainly around posterior two digits (Figure 4.5A).  By E8, exprssion is restricted to the surround 
muscle masses of the wing and in the mesoderm underlying the surface ectoderm (Figure 4.5 B-
C).   
The E6 hindlimb shows a similar expression pattern for fbxw4 as the forelimb, 
surrounding the presumptive digits (Figure 4.6A-B).  E8 hindlimbs also show dispersed 
expression throughout the mesoderm around the tarsometatarsus, but in the distal most regions 














































































































































































































































































































































































































































































































































































































































































































































































The most expansive expression pattern was that of fgf8.  In E6 forelimb, expression was 
localized to the ventral portion of the distal limb and i  between the presumptive digits.  More 
distally, expression was localized to the anterior and posterior regions, with discrete expression 
around the future digits (Figure 4.7 A-C).  By E8, the expression became localized adjacent to 
the bones (Figure 4.7 D), and distally in the central mesod rm beside the digits (Figure 4.7 E).   
Expression was not as widespread in the hindlimb, with the pattern more completely 
surrounding the digits in E6 limbs.  Expression was stronger in the ventrally side (Figure 4.8 A-
B).  Expression down regulated in the proximal tissue (bright spots are wax contamination), with 











































































































































































































































































































































































































































































































































































































































































































































Finally, the expression of sufu in E6 forelimb (Figure 4.9 A) was minimal, appearing to 
localize around the central presumptive digit (digit III).  At E8, this limited expression is now 
detected in the mesoderm cells underlying the surface ectoderm (Figure 4.9 B-D).  This is 
reminiscent of btrc E8 forelimb expression (Figure 4.9 D-F).   
In the hindlimb, expression appears restricted to the moredistal regions in both stages, 
and remains very minimal (Figure 4.10 A-G).  The several bright spots in these sections are the 






















































































































































































































































































































































































































































































































































































































































































































































RESULTS: SCREENING OF ENHANCER ELEMENTS IN SHFM3 AND SHFM5 LOCI 
 
 Using the Vista Enhancer Browser, (http://enhancer.lbl.gov/) to search for enhancer 
expression in the limb, revealed an enhancer within the SHFM5 locus as well as one within the 
SHFM3 locus.  Thus, patients with SHFM having no known molecular cause were screened for 
mutations in these sequences. 
 
Screening of the enhancer within the SHFM3 Locus 
 Screening of 57 patients with SHFM of unknown molecular causes using the BTRC EN1 
primers found a change in 36 patients.  For the enhancer within in ron 4-5 of BTRC a C-T change 
was observed.  Of these 36 patients, 27 were heterozygous for the change, while 9 were 
homozygous (Figure 5.1 A, B).  The change was confirmed in all of the patients using digesting 
with the restriction enzyme RsaI (Figure 5.1 C).   
Screening of 18 unaffected controls with RsaI digests found 6 that were heterozygous for 
the change and 9 that were homozygous, indicating that the change is not significant and most 
likely represents a single nucleotide polymorphism normal variant.  
 When screened with the BTRC EN1 primers, one patient had a G insertion at position 398 
of the enhancer sequence (Figure 5.2 A).  However, this initial sequencing result was of poor 
quality and further screening with BTRC EN4 primers showed no insertion (Figure 5.2 B). 
 
Screening of the Enhancer within the SHFM5 locus 
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 57 patients with SHFM of unknown molecular cause were sc ened.  Screening the 3’ 
sequence of the enhancer element, in the SHFM5 locus, includ g the ultra conserved region, 
showed no sequence changes (data not shown).  Thus this line of e quiry was not pursued 























































































































































































































































































Figure 5.2: Sequence trace data for patient with apparent insertion 
(A) Sequencing trace data from BTRC EN1 forward and reverse primer showing what 
appears to be a G insertion in both directions.  (B) Sequencing trace data of the same 





 A tandem duplication at chromosome 10q24 has been identified as the causative 
mutation for SHFM3 [28].  Patients heterozygous for the duplication have three full 
copies of the genes BTRC, DPCD, and POLL, as well an additional copy of exons 6-9 of 
FBXW4 [28, 47, 48].  Lymphoblasts from these patients over express th  duplicated gene 
BTRC, and SUFU, a gene that is downstream of the duplication [48].  FGF8, a gene also 
in the critical region, plays a key role in AER formation and maintenance [4].  Gene 
expression is time and tissue specific, and with the excption of FGF8, it was unknown if 
the genes of the SHFM3 critical region were even expressed in the developing limb.  
Even with the knowledge of FGF8, expression of this gene has not been studied from the 
emergence of the limb bud through digit formation.  
This study used both Reverse Transcriptase Polymerase Chain Re ction (RT-
PCR) and in situ hybridization in chick embryos as effective ways to identify candidate 
genes in and around the duplicated region.  Using this approach, a better understanding of 
the normal mRNA expression of the genes from the SHFM3 critical region, in the 
developing chicken limb, was achieved.  Moreover, these data provide the basis for 
pursuing these candidate genes in future studies, initially using the chick as a model 
system for gain- and loss-of-function studies of single genes and combinations of the 
candidate genes, and then moving to the mouse for transgenic stud es. 
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Genes in the duplicated region are expressed during chick limb development 
 
 All genes analyzed showed varying expression levels throughout stages E3-E13 
and, with the exception of poll, were further tested by in situ hybridization on sections 
from E6 and E8 forelimbs and hindlimbs.  Expression of btrc was very specific to mainly 
the mesoderm cells between the presumptive digits at E6.  BTRC has been implicated in 
apoptosis [50, 51], and if its expression marks the cells d stined to undergo apoptosis, 
over expression of BTRC has the potential to expand this region between the presumptive 
digits.  It is plausible that expansion of the region of apoptotic cells could prevent the 
central digits from developing properly, leading to the SHFM phenotype.   
 The localization of dpcd expression around the bones of the distal limb indicates a 
potential role in digit development or patterning.  The pattern of expression appears to be 
in the perichondrium sheath of the developing bones.  To better determine the type of 
tissue in which dpcd is expressed, sections should be staind with Alcian blue and 
Chlorantine fast red to distinguish between cartilage and ossified tissue, respectively.  
Deletion of Dpcd in mouse leads to the pulmonary ciliary dyskinesia (PCD) like 
phenotype, but no limb anomaly was reported [58].  Zariwala and coworkers suggest that 
DPCD is responsible for the formation or function of ciliated cells [58].  At the time of 
limb development in the chicken, over half the mesenchymal cells are ciliated, which 
correlates with the mitotic stage of the cell [59].  Cartilage cells in the developing limb 
are ciliated, thus, dpcd may be responsible for the proper formation of the cilia.  An over-
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expression of DPCD during limb development has the potential to affect patterning of the 
limb skeleton leading to the SHFM phenotype. 
 Mutations in the mouse homolog of FBXW4 have been implicated as the causative 
mutation in the Dactylaplasia (Dac) mouse mutant, which is the current model for 
SHFM3 [56].  Over the course of limb development, RT-PCR results indicate that fbxw4 
expression fluctuates.  In situ hybridization of E6 sections shows expression around the 
presumptive digits.  At E8, fbxw4 expression is around the muscle masses of the limbs.  
The mutations in the mouse model and human are different, but both involve the FBXW4 
gene, and is expressed around the presumptive digits during chick limb development.  
This suggests that the gene is a candidate for a role in th SHFM phenotype.  It is 
possible that the duplicated exons code for a protein that competitively interacts with the 
target protein of FBXW4.  This interaction could disrupt the normal pathway leading to 
the SHFM phenotype. 
 FGF8 is well documented as being crucial to AER formation and maintenance [1, 
49], but this study extends the reported stages of expression and shows that FGF8 is 
expressed well after the AER has disappeared.  In situ hybridization analysis shows 
localization of expression around the digits in E6 limbs.  Localization in E6 forelimbs to 
the ventral side suggests a role for fgf8 in dorsal ventral patterning of the forelimb only.  
Despite the lack of evidence implicating FGF8 in the manifestation of the SHFM 
phenotype, the crucial role FGF8 plays in limb development and the expression pattern 
found in this study, are sufficient evidence to study FGF8 further.  Although FGF8 is not 
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in the duplicated region, the duplication, found in SHFM3 patients, may remove FGF8 
from a regulatory element, thus affecting its expression levels and/or pattern. 
 Although not duplicated, SUFU is over expressed in SHFM3 patient lymphoblasts 
[48].  This could be a result of the over expression of BTRC, as the two genes, or their 
proteins, are believed to interact [49].  RT-PCR results demonstrate a similar time course 
to btrc, although expression in the sections is not as strong.  btrc is thought to act 
upstream of sufu, and further in situ hybridization studies using double staining with the 
btrc and sufu probes, over several substages, will be required to determine if this is 
indeed the case.  Similar to btrc, the expression pattern of sufu around the presumptive 
digits and its involvement in apoptosis [72, 73] indicate that an over expression of the 
gene may prevent the central digits from forming and leato the SHFM phenotype.  
RT-PCR showed that poll was detected at E6 in both forelimbs and hindlimbs, but 
not detected at any of the other stages tested.  Given the amount of rapidly proliferating 
cells in the developing limb, it is not surprising to find trace amounts of a DNA repair 
polymerase.  At E6, mesenchymal condensations undergo chondroge esis, and this spike 
in expression of poll may be a result of the number of cells differentiating into osteoblasts 
during this process.  Such limited expression likely eliminates POLL as a key player in 
limb development.  
 In summary, the results of this study indicate that BTRC, DPCD, FBXW4, FGF8, 
and SUFU are candidate genes for limb development and patterning, and th t altered 
expression of one or more of these genes may cause or contribute to the SHFM 
phenotype in patients who have duplications at the SHFM3 locus.   
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Quantitative gene analysis  
 
In order to better understand the role of each gene in normal development, and 
possibly how errors in the expression of these genes can lead to the SHFM3 phenotype, 
quantitative studies were necessary.  Expression levels of btrc, dpcd, fbxw4, and sufu 
change dynamically over the course of limb development.  To address these issues 
quantitative PCR (qPCR) was performed on E3-13 cDNA from frelimbs and hindlimbs.  
The expression of each gene was compared to that of control 18S rRNA at the same 
stage.  A number of general trends were identified, such as t e difference of sufu 
expression in the fore limbs compared to the other genes t sted.  The expression ratio of 
the test gene to the control gene rarely exceeded 1.0 for any stage tested.  In retrospect, 
the robust expression of 18S rRNA makes it a poor choice of a c ntrol gene for qPCR.  
These tests should be repeated with another control gene such as actin or GAPDH, to 
provide results that may be more conclusive.   
This study focused only on the expression of the genes in the limb, and did not 
compare the expression to that in the rest of the embryo.  Key stages in the development 
of the autopod such as the emergence of the limb bud, demarcation of presumptive digits, 
and end of digit formation, could be tested using the rest of the embryo from the same 
stage as a positive control sample.  If a particular gene has greater expression in the limb 
than the remainder of the embryo during key stages in limb development, it is possible 
that altered expression of that same gene can lead to an abnormal limb phenotype. 
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Future studies using the Dactylaplasia mouse mutant 
 
After determining which genes are up regulated in the limb at these critical stages, 
it would be beneficial to examine the expression of each gene in the developing limb of a 
Dac mutant mouse compared to that in a control wildtype mouse limb.  Since the 
mutation in the Dac mouse involves the Dactylin gene, it is expected that its expression 
would be altered.  However, because both forms of the mutation re chromosomal 
rearrangements, changes in the Dactylin gene might impact the expression of nearby 
genes.  Kano and coworkers studied the mRNA levels of Btrc, Poll, and Dpcd in wildtype 
and Dac embryos, but found no significant changes [79].  The study did not specify if the 
samples used were from the limbs or the whole embryo, or what stages were studied.  
Instead limb tissue from wildtype and both homozygous and heterozygous Dac embryos 
should be collected from key developmental stages and the expr ssion of the candidate 
genes analyzed using qPCR.  Genes that show a different expression level between the 
three genotypes should be considered candidate genes for further study. 
 
Future studies using the chick embryo 
 
 One current hypothesis is that the over expression of duplicated genes from this 
locus is the causative mechanism for the SHFM3 phenotype [48].  Genes that are found 
to be up regulated in Dac mouse can could be cloned into an over expression vector that 
is electroporated into a developing chicken embryo [81].  The embryo can then be 
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incubated until the end of limb development and the injected limb studied for a change in 
phenotype [81].  Given the location of btrc expression found in this study, and that Lyle 
and coworkers showed an over expression of BTRC in patient lymphoblasts, this is a 
promising candidate.  SUFU has also been shown to be over-expressed in patient 
lymphoblasts [48] and has a similar expression pattern to btrc. These two genes have 
been hypothesized to interact with each other [71].  It stands to reason that although 
SUFU is not duplicated in SHFM3 patients, if BTRC acts upstream of SUFU then an over 
expression of BTRC would lead to an over expression of SUFU.  Merely over expressing 
BTRC in the chicken model may lead to an increase in SUFU as well; however it may be 
necessary to over express SUFU independently and within a BTRC model system. 
 In SHFM3 patients, there is also a duplication of exons 6-9 of FBXW4.  It is 
possible that these three exons encode a protein that prevents the proper formation of the 
limb.  Transcription of these exons could also result in a short-interfering RNA (siRNA) 
that prevents proper translation of a gene transcript crucial for patterning of the hand or 
foot.  In vitro translation of the duplicated fragment in either orientation should determine 
if a protein is made.  If so, the fragment should also be cloned into an over-expression 
vector to test for any affect on limb phenotype in the c ick. 
 
Other experimental approaches 
 
 When comparing the expression of genes between the Dac limbs and the 
wildtype, it is possible that expression of some of these genes is reduced.  To test if the 
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lower expression of a gene results in the SHFM phenotype, knock-down morpholinos in 
zebrafish could be employed to lower expression of the candidate gene and observe the 
result on the phenotype. 
 A better experimental method to study the effect of this duplication on limb 
phenotype is to create a mouse model with the full duplication seen in SHFM3 patients.  
A conditional knock-in method is required to insert the duplicated region under the 
control of an inducible limb specific enhancer. 
 As stated above, the mouse model for SHFM3 is the result of insertion or 
inversion mutations of the Dactylin gene, the mouse homolog of FBXW4.  It is possible 
that the duplication seen in SHFM3 patients causes the phenotype by separating a gene, 
either within the critical region or further displaced, from a regulatory element.  This 
region should be studied for highly conserved, non-coding regions that could be 
candidate regulatory elements for genes involved in limb development.  Candidate 
elements can be cloned into a vector that when electroporated into the developing chick 
limb will express GFP in the tissue in the same pattern as the gene that the element 
enhances.  If such an element is found, patients with SHFM of unknown cause should be 
screened for mutations in these elements. 
 In summary, most of the genes in the SHFM3 critical region are expressed during 
the time of limb development in the chicken.  I  situ hybridization suggests that any or all 




Screening of VISTA enhancers 
 
 The Lawrence Berkeley National Laboratory is currently using a mouse model to 
identify non-coding elements with enhancer activity.  Two such elements, with enhancer 
activity in the limb, are located in SHFM loci.  One element located within intron 4-5 of 
BTRC in the SHFM3 locus (Figure 6.1), shows enhancer activity in he central region of 
the autopod, the same region that lacks digits in SHFM patients (Figure 6.1).  The second 
element, located within the SHFM5 locus, shows activity n the AER (Figure 6.2).  
Although these sequences do not code for protein, changes in the sequences could inhibit 
enhancer function.  Screening of both elements in 57 patients (this study) with SHFM for 
which the molecular cause is unknown found no significant sequence changes. 
 Microduplications of the SHH enhancer, ZRS, have been associated with the limb 
malformation triphalangeal thumb polysyndactyly [50].  Since BTRC is duplicated in 
SHFM3 patients, it is possible that the extra copy of the enhancer is responsible for the 
SHFM3 phenotype.  Patients that do not have a molecular diagnosis should be screened 
using qPCR for duplications of the enhancer within BTRC.  This technique was used to 




Figure 6.1: Enhancer element within BTRC 
Image from the VISTA enhancer browser of the expression of a reporter gene driven by 
an enhancer within intron 4-5 of BTRC in a mouse embryo.  This enhancer shows activity 




Figure 6.2: Enhancer element within SHFM5 locus 
Image from VISTA enhancer browser of the expression of a reporter gene driven by an 





RT-PCR and in situ hybridization analysis identified candidate genes in and 
around the SHFM3 critical region.  This study provided a better understanding of the 
normal mRNA expression patterns of btrc, poll, dpcd, fbxw4, fgf8, and sufu in the 
developing chicken limb, suggesting that with the exception of POLL, mis-expression of 
all of these genes are candidates for the causative agent of Split Hand/Foot Malformation.  
These data provide a baseline for pursuing future studies, initially using the chick and 
zebrafish as model systems for gain- and loss-of-functio  studies of the candidate genes 
both individually and in combination.  Mouse experimental approaches will further 





Appendix A Primer Sequences 
 
 
Gene Forward Primer Reverse Primer Annealing Temperature (°C) 
btrc GGC TGT GGG ATA TCG AGT GT TGA GGA TGG TGT CAT CGT GT 55 
poll GTG TGG CAT GTG GCT CCT AC CAG AGT CAC CAG TCC CGT TC 59 
dpcd ACG GGA AGC GGA AGA TCC CTC CTT TGG CTT CTG GTA CG 58 
fbxw4 GAG AAC ATC CAG GCC TAC CA CGC AGT TCA CCT CTT GTT CA 52 
fgf8 CAG AGC CTG GTG ACA GAT CA TTG CCT TTG CCG TTA CTC TT 50 
sufu GAA TGG GTT GAA CCA TGA CC TCA GGC CAG CTG GTA CTC TT 55 
18SrRNA CGG CGG CTT TGG TGA CTC TA CGC CGG TCC AAG AAT TTC AC 55 
 
Figure A-1 Primers Used in RT-PCR and Annealing Temperatures: Primer 
sequences for RT-PCR of each gene and the annealing temperature used.  All sequences 




Gene Forward Primer Reverse Primer 
btrc GGC TGT GGG ATA TCG AGT GT TGA GGA TGG TGT CAT CGT GT 
dpcd CAG TTT GAG GAT GGG AAG GA CAA TGG TCC CAG GAG AGG TA 
fbxw4 GAG AAC ATC CAG GCC TAC CA CGC AGT TCA CCT CTT GTT CA 
sufu ACG AAG ACA GCA GGA GCA TT GGT CAT GGT TCA ACC CAT C 
18 S rRNA CAT GGC CGT TCT TAG TTG GT GAC ACA AGC TGA GCC AGT CA 
 
Figure A-2 Primers Used in qPCR: Primer sequences of primers used in qPCR of each 
gene, annealing temperature was 55°C for all primer pairs.  All sequences are reported 5’ 
to 3’.
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Name Forward Primer Reverse Primer Annealing Temp (°C) 
EN 1 TCT AGC TGC AGG GGT TTT TG GAA CTT GAT CGA TGG CTG CT 59 
EN 2 GAA ACA TAA ACA CAG CGC TCA GCA CTG CAG CAA GCT CTA AA 58 
EN 3 GAA AGG CTG TGT CCT GAA ATG TGC AGT CAT TCC AAT TCC TTT 58 
EN 4 TCC CCA AGT CTG TAT CAC TGG ACC CCC TGG CAA ATT GTA  58 
 
Figure A-3 Primers Used to Sequence Enhancer Located in I tron 4-5 of BTRC and 
Annealing Temperatures: Sequencing and annealing temperatures for primers used in 
sequencing of enhancer elements within intron 4-5 of BTRC.  All sequences are reported 




Name Forward Primer Reverse Primer 
EN 4 GGT GTG AGA AGT CCCTTTGG TCA TAG ACT GGA AGC CAA AAC A 
EN 5 CCT GAT GGA GGA TAC TGA CCA CAA ATC AAA ACT ATC CAA AGC AAA 
EN 6 TGG AAA ATT GAA ACC ATG TGC TTT TAA AAT CCA GAT TGA ATG CTT 
 
Figure A-4 Primers used to Sequence Enhancer within PTD004 in the SHFM5 
Critical Region: Primers used to sequence the 3’ portion of the enhancer within PTD004.  
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